Suscribirse

LAPAROSCOPIC PYELOPLASTY - 05/09/11

Doi : 10.1016/S0094-0143(05)70119-1 
Günter Janetschek, MD *, Reinhard Peschel, MD *, Ferdinand Franscher, MD *

Resumen

For several decades, open surgical pyeloplasty was the only method available for the repair of ureteropelvic junction (UPJ) obstruction. Over the past few years, several alternative techniques, such as antegrade and retrograde endopyelotomy and laparoscopic pyeloplasty, have been developed. Patients benefit from these new methods because they are all less invasive and carry lower morbidity than open surgery; however, there is considerable variation with regard to the morbidity involved and their efficacy in relieving obstruction. If the least invasive technique produced the best functional results equal to those of open surgery, the choice of procedure would be straightforward; however, a direct comparison of the morbidity associated with the different techniques is problematic because prospective randomized trials have not been undertaken. A direct comparison of the functional results is even more problematic because the degree of obstruction is difficult to quantitate. Obviously, good results achieved with one technique might be even better if a different method had been applied, but it is impossible to demonstrate and quantitate these potential differences in terms of outcome; therefore, the failure rate may be a more suitable parameter for comparison. A prospective randomized study comparing the different methods on the basis of identical criteria would settle the issue, but thus far, the minimally invasive techniques have been compared with historical series of open surgery only.4 In small series, the data are influenced by the learning curve as well.5 For ethical reasons, a prospective randomized trial comparing laparoscopy and open surgery cannot be performed because all studies report similar efficacy but great differences in morbidity. This argument does not apply to the comparison of different minimally invasive techniques, such as retrograde endopyelotomy versus laparoscopic pyeloplasty. These techniques are indicated for different groups of patients, and only long-term follow-up over many years could reliably reveal all treatment failures. A reduction in morbidity, which is the major advantage of the new techniques, must be weighted against potential disadvantages, as can be seen from the failure rates, when deciding on the most suitable treatment modality for a given patient.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Günter Janetschek, MD, Department of Urology, KH der Elisabethinen, Fadingerstr. 1, A-4010 Linz, Austria, e-mail: günter.janetschek@elisabethincan.or.at


© 2000  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 27 - N° 4

P. 695-704 - novembre 2000 Regresar al número
Artículo precedente Artículo precedente
  • PERCUTANEOUS ENDOPYELOTOMY
  • Stevan B. Streem
| Artículo siguiente Artículo siguiente
  • LAPAROSCOPIC RADICAL NEPHRECTOMY FOR CANCER
  • Inderbir S. Gill

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.